DR.REDDY'S LABORATORIES LTD. - 500124 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Results of voting through Postal Ballot14-02-2024
14-02-2024
U.S. FDA Grants VAI Classification To Dr Reddy's R&D Centre
Dr Reddy's Laboratories on Monday said the US health regulator has granted Voluntary Action Indicated classification to its Hyderabad-based R&D centre post inspection.12-02-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Update On The USFDA Inspection At The Company'S R&D Centre (Integrated Product Development Organisation Or IPDO) In Bachupally, Hyderabad
Intimation under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) regulations, 2015 - Update on the USFDA inspection at the Company''s R&D centre (Integrated Product Development organisation or IPDO) in Bachupally, Hyderabad12-02-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Update On The USFDA Cgmp Inspection At The Company'S Formulations Manufacturing Facility (FTO-3) In Bachupally, Hyderabad
Intimatuin under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Update on the USFDA cGMP inspection at the Company''s formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad10-02-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate(s)07-02-2024
Stock to buy today: Dr Reddy's Laboratories (6,165.6)
Raise this to 6,050 when the share price hits 6,25007-02-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of earnings call conducted on January 30, 202405-02-2024
Neutral Dr Reddy's Labs; target of Rs 5540: Motilal Oswal
Motilal Oswal recommended Neutral rating on Dr Reddy's Labs with a target price of Rs 5540 in its research report dated January 31, 2024.03-02-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings02-02-2024
Dr Reddys Laboratories Q3 FY24 Results Live : profit rise by 11.01% YOY
Dr Reddys Laboratories Q3 FY24 Results Live : Revenue increased by 6.58% YoY & profit increased by 11.01% YoY01-02-2024